Registry for CADASIL
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT05567744
- Status
- Recruiting
Conditions
- Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- Registry — OTHERRegistry
Study Details
This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL or are at risk. Participation means that your name will be added to a list of people who will be invited to participate in future research studies on CADASIL. Participants must be 18 years or older, and will remain on the registry until they request to be removed.
Key Dates
- Start date
- Jun 3, 2022
- Status verified
- Oct 2025
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 2,500 participants (estimated)
Arms
- Arm: CADASIL Registry ParticipantsHave a loved one or family member with CADASIL, or anyone with or at risk for CADASIL
Primary Outcome Measure
A Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Registry [ Time Frame: Up to 20 years ]
Central Contacts
- CADASIL Consortium833-795-3016
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Wisconsin | Madison | Wisconsin | 53705 | Jane Paulsen, PhD (PRINCIPAL_INVESTIGATOR) |